AndrewAlanWizniaMD
Allergy & Immunology • Bronx, NYPediatric Asthma & Allergic Conditions
Professor, Pediatrics, Albert Einstein College of Medicine
Dr. Wiznia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1400 Pelham Pkwy S
# 5C-15
Bronx, NY 10461Phone+1 718-918-4664Fax+1 718-918-4699
Summary
- Dr. Andrew Wiznia is an allergist/immunologist in Bronx, NY and is affiliated with multiple hospitals in the area, including NYC Health + Hospitals / Jacobi, NYC Health + Hospitals / North Central Bronx, and NYC Health + Hospitals / Coney Island. He received his medical degree from Columbia University College of Physicians & Surgeons and has been in practice 37 years. He specializes in pediatric asthma & allergic conditions.
Education & Training
Montefiore Medical Center/Albert Einstein College of MedicineFellowship, Allergy and Immunology, 1984 - 1986
BronxCare Health SystemResidency, Pediatrics, 1983 - 1984
Jacobi Medical Center/Albert Einstein College of MedicineResidency, Pediatrics, 1980 - 1983
Columbia University Vagelos College of Physicians and SurgeonsClass of 1980
Certifications & Licensure
NY State Medical License 1982 - 2025- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2010-2014
- Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2010-2013
- Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2010-2013
- Join now to see all
Clinical Trials
- A Study to Test the Safety, Tolerance, and Metabolism of Abacavir (1592U89, ABC) With Standard Zidovudine (ZDV) Therapy in Newborn Infants Born to HIV-1 Infected Women
- A Study to Compare Two Different Anti-HIV Drug Regimens
- Safety and Effectiveness of Four Anti-HIV Drug Combinations in HIV-Infected Children and Teens
- Join now to see all
Publications & Presentations
PubMed
- 20 citationsEmergence of Resistance in HIV-1 Integrase With Dolutegravir Treatment in a Pediatric Population From the IMPAACT P1093 Study.Cindy Vavro, Theodore Ruel, Andrew Wiznia, Nicole Montañez, Keith Nangle
Antimicrobial Agents and Chemotherapy. 2021-10-25 - 4 citationsPredictors of attempted suicide among youth living with perinatal HIV infection and perinatal HIV exposed uninfected counterparts.Philip Kreniske, Claude A. Mellins, Curtis Dolezal, Corey Morrison, Eileen Shea
Journal of Acquired Immune Deficiency Syndromes. 2021-08-16 - 3 citationsEtravirine in treatment-experienced HIV-1-infected children 1 year to less than 6 years of age.Christine E. MacBrayne, Richard M. Rutstein, Andrew Wiznia, Bobbie Graham, Carmelita Alvero
AIDS. 2021-07-15
Grant Support
- Bronx/Lebanon Pediatric ActuNational Institute Of Allergy And Infectious Diseases1997–1998
- AIDS Clinical TrialsNational Institute Of Allergy And Infectious Diseases1994–1996
- Bronx-Lebanon Pediatric ActuNational Institute Of Allergy And Infectious Diseases1992–1993
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
